NFKB1 and neoplasm: These surviving tumor cells acquire enhanced tumorigenic and metastatic capabilities by activating ATF4‐dependent nonclassical NF‐κB signaling pathway, which provides a new mechanistic explanation for chemotherapy‐induced tumor metastasis.